Ultima Genomics - About the company
Ultima Genomics is a series D company based in Newark (United States), founded in 2016 by Gilad Almogy. It operates as a Developer of high-throughput NGS instrument for research. Ultima Genomics has raised $600M in funding, with a current valuation of $*****. The company has 126 active competitors, including 39 funded and 29 that have exited. Its top competitors include companies like Nanopore Technologies, PacBio and Complete Genomics.
Company Details
Developer of high-throughput NGS instrument for research. The company has developed a fundamentally new sequencing architecture including completely different flow cell engineering, sequencing chemistry, and machine learning. The company has currently in an early access program for the UG 100, its first high-throughput NGS instrument using this new technology architecture which enables customers to generate high-quality sequencing data.
- Website
- www.ultimagenomics.com/
- Social
- Email ID
- *****@ultimagenomics.com
Key Metrics
Founded Year
2016
Location
Newark, United States
Stage
Series D
Total Funding
$600M in 3 rounds
Latest Funding Round
Post Money Valuation
$***** as on May 31, 2022
Investors
Ranked
4th among 126 active competitors
Employee Count
309 as on Sep 30, 2026
Similar Companies
Sign up to download Ultima Genomics' company profile
Ultima Genomics's funding and investors
Ultima Genomics has raised a total funding of $600M over 3 rounds. Its first funding round was on May 22, 2019. Its latest funding round was a Series D round on May 31, 2022 for $*****. 9 investors participated in its latest round. Ultima Genomics has 9 institutional investors and 1 angel investor.
Here is the list of recent funding rounds of Ultima Genomics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 31, 2022 | 8495327 | Series D | 3881389 | 6578097 | 7807279 | 1477136 |
May 01, 2020 | 2938153 | Grant (prize money) | 8867333 | 7398229 | 8468338 | |
May 22, 2019 | 9322748 | Grant (prize money) | 7111486 | 6506483 | 4047030 |
Access funding benchmarks and valuations. Sign up today!View details of Ultima Genomics's funding rounds and investors
Ultima Genomics' founders and board of directors
Founder? Claim ProfileThe founders of Ultima Genomics is Gilad Almogy. Gilad Almogy is the CEO of Ultima Genomics.
Here are the details of Ultima Genomics' key team members:
- Gilad Almogy: Co-Founder & CEO of Ultima Genomics.
View details of Ultima Genomics's Founder profiles and Board Members
Ultima Genomics' employee count trend
Ultima Genomics has 309 employees as of Sep 26. Here is Ultima Genomics's employee count trend over the years:
Uncover Ultima Genomics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Ultima Genomics's Competitors and alternates
Top competitors of Ultima Genomics include Nanopore Technologies, PacBio and Complete Genomics. Here is the list of Top 10 competitors of Ultima Genomics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Nanopore Technologies 2005, Oxford (United Kingdom), Public | Manufacturer of portable and benchtop devices for real-time DNA sequencing | $1.34B | 75/100 | |
2nd |  PacBio 2004, Menlo Park (United States), Public | Developer of instrument systems and software for real-time sequencing of single-molecules | $410M | 72/100 | |
3rd | Complete Genomics 2006, San Jose (United States), Acquired | Developer of DNA sequencing platform for human genome sequencing and analysis | $125M | 66/100 | |
4th |  Ultima Genomics 2016, Newark (United States), Series D | Developer of high-throughput NGS instrument for research | $600M | 59/100 | |
5th |  S2 Genomics 2016, Livermore (United States), Acquired | Developer of automated sample preparation systems for genomics | $16M | 58/100 | |
6th |  Bionano 2002, San Diego (United States), Public | Provider of genome analysis solutions to researchers and clinicians | $124M | 58/100 | |
7th | Singular Genomics 2016, San Diego (United States), Acquired | Provider of next-generation gene sequencing and multi-omics technologies | - | 57/100 | |
8th | Bioskryb 2018, Durham (United States), Seed | Developer of a genome sequencing and amplification system | $11.5M | 55/100 | |
9th | _1586858599436.png?devicePixelRatio=2&height=30&width=30){kind=logo} Protillion 2018, Burlingame (United States), Series A | Provider of platform for protein analysis | $19M | 53/100 | |
10th | ReadCoor 2016, Cambridge (United States), Acquired | Innovating single-cell, spatial, and in situ biology tools for researchers | $55.6M | 51/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Ultima Genomics's competitors? Click here to see the top ones
Ultima Genomics's Investments and acquisitions
Ultima Genomics has made no investments or acquisitions yet.
Reports related to Ultima Genomics
Here is the latest report on Ultima Genomics's sector:
News related to Ultima Genomics
Filter this listMedia has covered Ultima Genomics for a total of 3 events in the last 1 year, 3 of them have been about company updates.
•
Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas InitiativeGlobeNewswire•Mar 18, 2026•Basecamp Research, PacBio, Microsoft, Ultima Genomics and 2 others
•
Ultima Genomics Selected for Regeneron Genetics Center Proteomics StudiesPR Newswire•Jun 27, 2025•Ultima Genomics, Regeneron Pharmaceuticals
•
BioSkryb Genomics and Ultima Genomics Launch Collaborative Grant Program to Advance Oncology ResearchBusiness Wire•Apr 23, 2025•Bioskryb, Ultima Genomics
•
Ultima Genomics Sequencing Platform Selected for UK Biobank StudyBio-IT World•Feb 14, 2025•Ultima Genomics, UK Biobank
•
Ultima Genomics Announces UG 100™ Sequencing Platform Selected for UK Biobank's Groundbreaking Human Proteome StudyPR Newswire•Jan 10, 2025•Ultima Genomics, UK Biobank
•
SolarEdge Appoints New Directors to its Board of DirectorsBusiness Wire•Jan 08, 2025•SolarEdge, General Atlantic, Ultima Genomics
•
Parse Launches GigaLab to Scale Single Cell Sequencing to Billions of Cells AnnuallyFinancial Post•Oct 29, 2024•Parse Biosciences, Ultima Genomics
•
Myriad Genetics and Ultima Genomics to Explore the UG 100™ Sequencing Platform to Advance Clinical Test Offerings in Oncology and Reproductive GenomicsGlobeNewswire•Oct 03, 2024•Myriad Genetics, Ultima Genomics
•
Pangea Biomed Partners with Hadassah and Ultima Genomics for Solid Tumor Cancer Treatment Research at Sharett Cancer InstituteWebwire•Aug 07, 2024•Pangea Biomed, Hadassah, Ultima Genomics, Hadassah
•
Ultima Genomics Adds Former Thermo Fisher Exec Mark Stevenson to Board of DirectorsBusiness Wire•May 02, 2024•Ultima Genomics, Thermo Fisher Scientific
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Ultima Genomics
Explore our recently published companies
- Lonbon - Unfunded company
- Curiosity - Bentonville based, 2014 founded, Unfunded company
- x-matic GesmbH - Unfunded company
- Systems Tek - Mumbai based, 1987 founded, Unfunded company
- Vance P. Hedderel - Unfunded company
- TrueUp Labs - Unfunded company
